Regulatory Management Only: TRIO-US Central Administration — Los Angeles, California

Regulatory Management Only: TRIO-US Central Administration is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Regulatory Management Only: TRIO-US Central Administration has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Metastatic Colorectal Cancer, Breast Neoplasms, Non Small Cell Lung Cancer (NSCLC).

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regulatory Management Only: TRIO-US Central Administration?

Regulatory Management Only: TRIO-US Central Administration has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regulatory Management Only: TRIO-US Central Administration conducted?

Regulatory Management Only: TRIO-US Central Administration has 4 clinical trials on record, with 1 currently active. Their work covers Metastatic Colorectal Cancer, Breast Neoplasms, Non Small Cell Lung Cancer (NSCLC).

Is Regulatory Management Only: TRIO-US Central Administration accredited by Crixeo Health?

Regulatory Management Only: TRIO-US Central Administration has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regulatory Management Only: TRIO-US Central Administration?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.